MHP has released the following update:

MHP Priority Care and MHP Pediatrics walk-in volumes have remained very busy and higher than normal volumes, but slightly less busy than last week’s volumes.

The Emergency Department saw 91 patients Sunday, which is significantly above normal volumes.

All 40 inpatients beds are occupied on our 3rd floor inpatient unit, including the ICU.

MHP currently has 17 critical care patients on the third floor and 11 patients are on ventilators, plus seven additional patients that are on Vapotherm or BiPap. Of the 11 patients on a ventilator, only only is vaccinated. Seven of the 11 ventilated patients are due to COVID.

Fifteen inpatients are COVID positive and 12 of those inpatients are unvaccinated.

MHP has 12 inpatients in the ACC department and all of those are non-COVID.

A total of 10 employees are out with COVID or suspected COVID at this time. Two employees have returned to work after completing their quarantine period.

MHP has zero remaining doses of Regeneron, the antibody treatment used to treat COVID-19.

They have 70 remaining doses of the Eli Lilly infusion drug Bamlanivimab (BAM). They had 19 infusions scheduled Monday, so they expected the remaining supply to dissipate quickly. Both drugs are on allocation, and MHP does not know when or if they will receive additional shipments.